Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications

Moritz Reese1, Sameer A Dhayat2

  • 1Department of General, Visceral and Transplant Surgery, University Hospital Muenster, Albert-Schweitzer-Campus 1 (W1), 48149, Muenster, Germany.

Insights

Small extracellular vesicles (sEVs) carry non-coding RNAs (ncRNAs) in pancreatic cancer, influencing disease progression and offering potential as diagnostic biomarkers and therapeutic delivery vehicles.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Pancreatic cancer exhibits a poor prognosis due to aggressive traits, late diagnosis, and treatment resistance.
  • Non-coding RNAs (ncRNAs) are key gene expression regulators, with their dysregulation linked to cancer development.
  • Small extracellular vesicles (sEVs) mediate intercellular communication via ncRNA transfer within the tumor microenvironment.

Purpose of the Study:

  • To review the role of sEVs as carriers of ncRNAs in pancreatic cancer.
  • To explore the molecular mechanisms by which sEV-ncRNAs influence pancreatic cancer hallmarks.
  • To discuss the potential of sEV-ncRNAs as diagnostic biomarkers and therapeutic delivery systems.

Main Methods:

  • Literature review focusing on the role of ncRNAs and sEVs in pancreatic cancer.
  • Analysis of molecular mechanisms underlying sEV-mediated ncRNA transfer.
  • Evaluation of current research on sEV-ncRNAs for diagnostic and therapeutic applications.

Main Results:

  • sEVs facilitate the intercellular transfer of ncRNAs (miRNAs, lncRNAs, circRNAs) in pancreatic cancer.
  • sEV-ncRNAs contribute to cancer hallmarks including angiogenesis, immune evasion, and metastasis.
  • sEV-ncRNAs show promise as non-invasive liquid biopsy biomarkers for diagnosis and prognosis.

Conclusions:

  • sEVs are crucial mediators of ncRNA-based intercellular communication in pancreatic cancer.
  • sEV-ncRNAs represent a significant area for biomarker discovery and development.
  • sEVs hold potential as effective delivery vehicles for ncRNA-based pancreatic cancer therapies.

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.0K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.1K